Clinical and Digital Interventions for Mental Health in Children and Young Adults

Keralty is an international integrated health group providing care to 9 million patients with 27,000 professionals across Colombia, Peru, Mexico, and the United States, combining healthcare delivery with digital innovation, social care, and disease management. Keralty has a solid track record in H2020 and Horizon Europe projects, contributing structured cohorts, clinical expertise, and implementation capacity.

In its specialised medical centres, Keralty works extensively on mood alterations and mental disorders that threaten the social, educational, and work stability of patients and healthcare professionals. This includes anxiety, depression, behavioural disorders, sleep disturbances, and other conditions that may be caused or aggravated by digital technology use, particularly among children, adolescents, and young adults.

Keralty is well positioned to support clinical and cohort studies under HORIZON-HLTH-2026-01-DISEASE-02 by offering:

• Access to large, diverse patient populations and real-world clinical settings

• Experience in longitudinal follow-up, disease management, and prevention programmes

• Capacity to implement digital and hybrid interventions in routine care

• Advanced data collection, automation, and analytics, generating actionable insights from clinical and behavioural data

Keralty’s integrated care model enables the co-design and testing of innovative digital interventions together with patients, families, carers, and healthcare professionals, supporting behaviour change, resilience building, digital literacy, and responsible use of digital technologies. The organisation can contribute to assessing behavioural, cognitive, and clinical outcomes, as well as the scalability and transferability of interventions across different contexts.

In addition, BioKeralty Research Institute, part of Keralty’s R&D&I division, can participate as a complementary partner. BioKeralty has strong expertise in digital health, personalised medicine, chronic diseases, and community care, as well as in communication, dissemination, and exploitation of results, supporting impact, uptake, and policy relevance.

Together, Keralty and BioKeralty offer a strong combination of clinical research capacity, real-world cohorts, digital health expertise, SSH-sensitive approaches, and implementation experience, and are keen to collaborate with universities, research centres, SMEs, technology developers, and public actors in ambitious consortia addressing the mental health impacts of digital technologies on children and young adults.